Unlocking the potential with the use of check-point inhibitor immunotherapies in metastatic prostate cancer

被引:2
作者
Revannasiddaiah, Swaroop [1 ]
Gupta, Ishu [1 ]
Devadas, Santhosh Kumar [1 ]
机构
[1] Ramaiah Med Coll, Dept Med Oncol, Bengaluru 560054, India
关键词
D O I
10.21037/cco.2019.01.07
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:2
相关论文
共 4 条
[1]   Immunotherapy in Prostate Cancer: Teaching an Old Dog New Tricks [J].
Comiskey, Michael C. ;
Dallos, Matthew C. ;
Drake, Charles G. .
CURRENT ONCOLOGY REPORTS, 2018, 20 (09)
[2]   Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math [J].
Giordano, Frank A. ;
Veldwijk, Marlon R. ;
Herskind, Carsten ;
Wenz, Frederik .
STRAHLENTHERAPIE UND ONKOLOGIE, 2018, 194 (10) :873-875
[3]   Immunotherapy: a glimmer of hope for metastatic prostate cancer [J].
Jindal, Vishal .
CHINESE CLINICAL ONCOLOGY, 2018, 7 (06)
[4]   Immunological Mechanisms Responsible for Radiation-Induced Abscopal Effect [J].
Rodriguez-Ruiz, Maria E. ;
Vanpouille-Box, Claire ;
Melero, Ignacio ;
Formenti, Silvia Chiara ;
Demaria, Sandra .
TRENDS IN IMMUNOLOGY, 2018, 39 (08) :644-655